Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle Are They Therapeutically Equivalent?

被引：6
|
作者：
Ravenstijn, Paulien [1 ]
Samtani, Mahesh [2 ]
Russu, Alberto [1 ]
Hough, David [3 ]
Gopal, Srihari [3 ]
机构：
[1] Janssen Res & Dev LLC, Beerse, Belgium
[2] Janssen Res & Dev LLC, Raritan, NJ USA
[3] Janssen Res & Dev LLC, Titusville, NJ USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 06期
关键词：
SCHIZOPHRENIA; INJECTIONS;
D O I：
10.1097/JCP.0000000000000610
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：744 / 745
页数：2
相关论文
共 50 条
  • [41] Effectiveness of paliperidone palmitate long-acting injectable in the initial stages of psychosis: Clinical and functional impact
    Balanco, L. Sanchez
    Revuelta, M. Gomez
    Galan, V. Gajardo
    Ruiz, M. Juncal
    Rodriguez, R. Landera
    de Santayana Jenaro, G. Pardo
    Olivares, O. Porta
    Morales, N. I. Nunez
    EUROPEAN PSYCHIATRY, 2017, 41 : S279 - S279
  • [42] Evaluation of the pharmacokinetic profile of gluteal versus deltoid intramuscular injections of paliperidone palmitate 100 mg equivalent in patients with schizophrenia.
    Cleton, A.
    Rossenu, S.
    Hough, D.
    Crauwels, H.
    Vandebosch, A.
    Berwaerts, J.
    Eerdekens, M.
    Francetic, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S31 - S31
  • [43] Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study
    Cai, Qian
    Patel, Charmi
    Kim, Edward
    Connolly, Nancy
    Tunceli, Ozgur
    El Khoury, Antoine C.
    ADVANCES IN THERAPY, 2019, 36 (04) : 858 - 869
  • [44] Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study
    Qian Cai
    Charmi Patel
    Edward Kim
    Nancy Connolly
    Ozgur Tunceli
    Antoine C. El Khoury
    Advances in Therapy, 2019, 36 : 858 - 869
  • [45] Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison
    Pae, Chi-Un
    Wang, Sheng-Min
    Han, Changsu
    Bahk, Won-Myong
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Prakash S.
    Serretti, Alessandro
    Emsley, Robin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (05) : 235 - 248
  • [46] Onset of Efficacy of Long-acting Injectable Paliperidone Palmitate for Negative Symptoms and Anxiety/Depression in Subjects With Schizophrenia
    Fu, Dong-Jing
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Ma, Yi-Wen
    Alphs, Larry
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S511 - S512
  • [47] Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
    Such, Pedro
    Olivares, Jose Manuel
    Arias, Lizbeth
    Berg, Mette Troels
    Madera, Jessica
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 1881 - 1892
  • [48] Development of a long-acting intramuscularly injectable formulation with nanosuspension of andrographolide
    Hu, Liandong
    Yang, Chenchen
    Kong, Dongqian
    Hu, Qiaofeng
    Gao, Na
    Zhai, Fuxin
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2016, 35 : 327 - 332
  • [49] Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
    Javier Quintero
    Itziar Oyagüez
    Beatriz González
    Ignacio Cuervo-Arango
    Ignacio García
    Miguel Angel Casado
    Clinical Drug Investigation, 2016, 36 : 479 - 490
  • [50] Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain
    Quintero, Javier
    Oyaguez, Itziar
    Gonzalez, Beatriz
    Cuervo-Arango, Ignacio
    Garcia, Ignacio
    Angel Casado, Miguel
    CLINICAL DRUG INVESTIGATION, 2016, 36 (06) : 479 - 490
12345